Apr 02, 2012 09:45 AM EDT
'Druggable' Protein Complex Identified as a Therapeutic Target in Acute Myeloid Leukemia
Scientists at Cold Spring Harbor Laboratory have identified a candidate drug target for treating acute myeloid leukemia (AML), a white blood cell cancer that proliferates out of control in the bone marrow. The team, led by Assistant Professor Chris Vakoc, M.D., Ph.D., shows that blocking a protein c...